Blood Flow Restriction Therapy in Patellofemoral Pain Syndrome

NYU Langone Health

Status: Terminated

Conditions: Patellofemoral Pain Syndrome

Treatments: Procedure: Personalized Tourniquet System for Blood Flow Restriction; Procedure: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT03717532

18-01123

Details and patient eligibility

About

The purpose of this study is to determine the efficacy of blood restriction therapy by comparing increase in muscle mass and strength in patients that receive blood restriction therapy to patients who receive a placebo.

Enrollment: 1 patient

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ASA class I-II
• Diagnosed with patellofemoral pain syndrome

Exclusion criteria

• Patients with confirmed radiographic evidence explaining knee pain
• Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia, etc.)
• Younger than 18 years of age or older than 65
• Any patient considered a vulnerable subject
• Patients with impaired circulation, peripheral vascular compromise, Previous revascularization of the extremity, or severe hypertension
• Patients with Sickle cell anemia or venous thromboembolism
• Patients with Sickle cell anemia or venous thromboembolism
• Patients with cancer or Lymphectomies
• Patients with increased intracranial pressure

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

1 participants in 2 patient groups, including a placebo group

Patients with Patellopain syndrome with Cuff

Experimental group

Description:

Patient will be prescribed to 6 weeks of physical therapy with a cuff around the affected leg during exercises

Treatment:

Procedure: Personalized Tourniquet System for Blood Flow Restriction

Patients with Patellopain syndrome with Placebo Cuff

Placebo Comparator group

Treatment:

Procedure: Placebo